Working towards a risk prediction model for neural tube defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 3, 2012, Pages 141-146

  Agopian, A J ^a   Lupo, Philip J ^a   Tinker, Sarah C ^b   Canfield, Mark A ^c   Mitchell, Laura E ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Anencephaly; Congenital abnormalities; Neural tube; Prediction; Risk score; Spina bifida

Indexed keywords

ANENCEPHALUS; ARTICLE; CLASSIFICATION AND REGRESSION TREE ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGENY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SPINA BIFIDA;

ANENCEPHALY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MALE; NEURAL TUBE DEFECTS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SPINAL DYSRAPHISM;

EID: 84858178283     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.22883     Document Type: Article

References (41)

1. Ahrens K, Yazdy MM, Mitchell AA, et al. 2011. Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology 22: 731-737.
2. Bailey LB, Rampersaud GC, Kauwell GP, et al. 2003. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 133: 1961S-1968S.
3. Barlow WE, White E, Ballard-Barbash R, et al. 2006. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98: 1204-1214.
4. Becerra JE, Khoury MJ, Cordero JF, et al. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85: 1-9.
5. Bewick V, Cheek L, Ball J, et al. 2004. Statistics review 13: receiver operating characteristic curves. Crit Care 8: 508-512.
6. Breiman L. 1984. Classification and regression trees. Belmont, Calif.: Wadsworth International Group.
7. Canfield MA, Honein MA, Yuskiv N, et al. 2006. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76: 747-756.
8. Canfield MA, Ramadhani TA, Shaw GM, et al. 2009. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 85: 637-646.
9. Correa A, Gilboa SM, Besser LM, et al. 2008. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199: 237, e231-e239.
10. D'Agostino RB, Sr., Vasan RS, Pencina MJ, et al. 2008. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753.
11. D'Agostino RB, Wolf PA, Belanger AJ, et al. 1994. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25: 40-43.
12. Duong HT, Shahrukh Hashmi S, Ramadhani T, et al. 2011. Maternal use of hot tub and major structural birth defects. Birth Defects Res A Clin Mol Teratol 91: 836-841.
13. Farooq V, Brugaletta S, Vranckx P, et al. 2011. A guide to interpreting and assessing the performance of prediction models. EuroIntervention 6: 909-912.
14. Feuchtbaum LB, Currier RJ, Riggle S, et al. 1999. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test 3: 265-272.
15. Institute of Medicine. 1999. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press.
16. Katz MH. 2006. Multivariable analysis: a practical guide for clinicians. 2nd ed. Cambridge, New York: Cambridge University Press.
17. Lammer EJ, Sever LE, Oakley GPJr. 1987. Teratogen update: valproic acid. Teratology 35: 465-473.
18. Lemon SC, Roy J, Clark MA, et al. 2003. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 26: 172-181.
19. Lupo PJ, Etheredge AJ, Agopian A, Mitchell LE. 2010a. Epidemiology of neural tube defects. In: Sheiner E, editor. Perinatal epidemiology. Hauppauge, NY: Nova Science Publishing. pp. 411-438.
20. Lupo PJ, Symanski E, Waller DK, et al. 2010b. Polytomous logistic regression as a tool for exploring heterogeneity across birth defect subtypes: an example using anencephaly and spina bifida. Birth Defects Res A Clin Mol Teratol 88: 701-705.
21. Milunsky A, Ulcickas M, Rothman KJ, et al. 1992. Maternal heat exposure and neural tube defects. JAMA 268: 882-885.
22. Mitchell LE. 2005. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 135C: 88-94.
23. Mosley BS, Cleves MA, Siega-Riz AM, et al. 2009. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 169: 9-17.
24. Parker SE, Mai CT, Canfield MA, et al. 2010. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88: 1008-1016.
25. Rasmussen SA, Chu SY, Kim SY, et al. 2008. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 198: 611-619.
26. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
27. Rosa FW. 1991. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324: 674-677.
28. Rowland CA, Correa A, Cragan JD, et al. 2006. Are encephaloceles neural tube defects? Pediatrics 118: 916-923.
29. Royston P, Moons KG, Altman DG, et al. 2009. Prognosis and prognostic research: Developing a prognostic model. BMJ 338: b604.
30. Seller MJ. 1987. Neural tube defects and sex ratios. Am J Med Genet 26: 699-707.
31. Shaw GM, Carmichael SL, Kaidarova Z, et al. 2003. Differential risks to males and females for congenital malformations among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol 67: 953-958.
32. Shaw GM, Todoroff K, Velie EM, et al. 1998. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 57: 1-7.
33. Shaw GM, Velie EM, Schaffer D, et al. 1996. Risk of neural tube defect-affected pregnancies among obese women. JAMA 275: 1093-1096.
34. Spitz MR, Hong WK, Amos CI, et al. 2007. A risk model for prediction of lung cancer. J Natl Cancer Inst 99: 715-726.
35. Toriello HV. 2011. Policy statement on folic acid and neural tube defects. Genet Med 13: 593-596.
36. Trepanier A, Ahrens M, McKinnon W, et al. 2004. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns 13: 83-114.
37. Waller DK, Mills JL, Simpson JL, et al. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170: 541-548.
38. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161: 745-750.
39. Willett W, Lenart E. 1998. Reproducibility and validity of food-frequency questionnaires. Nutritional epidemiology. New York: Oxford University Press. pp. 101-147.
40. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116( Suppl 1): 32-40.
41. Zhang H. 1998. Classification trees for multiple binary responses. J Am Stat Assoc 93: 180-193.